Mode
Text Size
Log in / Sign up

Depression prevalence reaches 50.9% among patients with advanced cancer receiving palliative careOver half of patients with advanced cancer face depression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note the high prevalence of depression (50.9%) in advanced cancer patients to inform screening and care strategies.

This meta-analysis synthesized data from 29 studies involving 6054 patients receiving palliative care for advanced cancer to determine the prevalence of depression. The analysis utilized self-report instruments for assessment across various study designs and tools.

The primary finding is a pooled prevalence of depression of 50.9% (95% CI: 41.2-60.5%). Secondary analyses explored how study design and specific assessment tools influenced these prevalence rates, though the high volume of data underscores the widespread nature of the condition in this population.

A significant limitation noted by the authors is the extremely high statistical heterogeneity that remained largely unexplained even after performing subgroup analyses and meta-regression. Because of this heterogeneity, the pooled estimate should be interpreted with caution.

Clinically, these findings suggest that depression is highly prevalent among patients with advanced cancer receiving palliative care. The results emphasize the necessity for clinicians to adopt suitable assessment tools and implement valid screening and care strategies to address mental health needs in this patient population.

How this fits prior evidence

This meta-analysis addresses a gap in understanding the prevalence of mental health conditions specifically within the palliative care setting for advanced cancer. While prior coverage noted that air pollution exposure is associated with increased risk of depression, this study provides specific quantification of depression prevalence (50.9%) in an advanced cancer population. It confirms that depression is a widespread issue among these patients, necessitating integrated screening tools.

Living with advanced cancer is physically and emotionally taxing. For many patients receiving palliative care, the mental toll can be just as heavy as the physical symptoms. New data shows that depression is incredibly common in this group, affecting over half of the people involved in the study.

Researchers looked at 6054 patients across 29 different studies to get a clearer picture. They found a pooled prevalence of depression at 50.9 percent. This high number suggests that mental health struggles are not rare occurrences but are common experiences for those facing advanced illness.

While the data shows how widespread this issue is, the researchers noted some uncertainty in the numbers because of high statistical differences between the studies they combined. Even so, the findings make it clear that using the right screening tools and care strategies is essential to support patients through their journey.

What this means for you:
Over half of patients with advanced cancer experience depression, making mental health screening a priority.

Common questions

How common is depression in people with advanced cancer?

Depression is very common in this group. A review of 29 studies involving 6054 patients found a prevalence rate of 50.9 percent for those receiving palliative care. This means more than half of the patients studied were experiencing symptoms of depression.

Is the data on cancer-related depression reliable?

The study shows that depression is widespread, but researchers noted that there was high statistical heterogeneity. This means there were many differences between the studies combined, so the 50.9 percent figure should be interpreted with some caution.

Why is it important to screen for depression in cancer care?

Because depression is so common among patients with advanced cancer, using proper assessment tools and screening strategies is essential. Identifying these issues early helps ensure that patients receive the right support during their treatment.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundAlthough the prevalence of depression in patients with advanced cancer receiving palliative care has been widely reported, the estimates vary substantially. This meta-analysis aimed to determine the pooled prevalence of depression in patients with advanced cancer receiving palliative care and identify its potential moderating factors.MethodsA comprehensive literature search was conducted in PubMed, Web of Science, Scopus, Embase, Cochrane Library, CINAHL, and PsycINFO from inception to April 1, 2026. We calculated pooled prevalence estimates using a random-effects model and assessed heterogeneity using the I² statistic. Subgroup analyses and meta-regression were performed to explore potential sources of heterogeneity.ResultsA total of 29 studies comprising 6054 patients with advanced cancer receiving palliative care were included, yielding a pooled prevalence of depression of 50.9% (95% CI: 41.2-60.5%). Subgroup analyses and meta-regression showed that the pooled prevalence varied significantly by study design and assessment tool.ConclusionsOur findings indicated that depression was very prevalent in patients with advanced cancer receiving palliative care. However, the pooled estimate should be interpreted with caution because the extremely high statistical heterogeneity remained largely unexplained, even after conducting subgroup analyses and meta-regression. Furthermore, the adoption of suitable assessment tools and the implementation of valid screening and care strategies are essential to alleviate emotional distress in this vulnerable group.Systematic review registrationPROSPERO, identifier CRD420261368352
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.